Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Summary
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Press Release : Addex Reports Q1 2021 Financial -2-

05/05/2021 | 01:00am EDT
" "plan," "anticipate," "intend," "believe," "estimate," "predict," 
"project," "potential," "continue," "target" and similar expressions are 
intended to identify forward-looking statements, although not all 
forward-looking statements contain these identifying words. Any 
forward-looking statements in this press release, are based on 
management's current expectations and beliefs and are subject to a 
number of risks, uncertainties and important factors that may cause 
actual events or results to differ materially from those expressed or 
implied by any forward-looking statements contained in this press 
release, including, without limitation, uncertainties related to market 
conditions. These and other risks and uncertainties are described in the 
Company's Annual Report on Form 20-F filed with the SEC on March 11, 
2021, as well as market conditions and regulatory review. 
 
   Any forward-looking statements contained in this press release represent 
Addex Therapeutics' views only as of the date hereof and should not be 
relied upon as representing its views as of any subsequent date. Addex 
Therapeutics explicitly disclaims any obligation to update any 
forward-looking statements, except as required by law. 
 
 
 
 

(END) Dow Jones Newswires

May 05, 2021 01:00 ET (05:00 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
ADDEX THERAPEUTICS LTD -0.69% 1.44 Delayed Quote.-27.14%
DJ INDUSTRIAL 1.06% 34382.13 Delayed Quote.9.74%
All news about ADDEX THERAPEUTICS LTD
01:00aPRESS RELEASEá : Addex Convenes Annual General Meeting 2021
DJ
01:00aAddex Convenes Annual General Meeting 2021
GL
05/05ADDEX THERAPEUTICSá : Unaudited Condensed Consolidated Financial Statements
PU
05/05ADDEX THERAPEUTICSá : Q1 Loss Shrinks on Positive Finance Income
MT
05/05PRESS RELEASEá : Addex Reports Q1 2021 Financial -2-
DJ
05/05PRESS RELEASE : Addex Reports Q1 2021 Financial Results and Provides Corporate U..
DJ
05/05Addex Reports Q1 2021 Financial Results and Provides Corporate Update
GL
05/03PRESS RELEASE : Addex Therapeutics to Release Q1 2021 Financial Results and Host..
DJ
05/03Addex Therapeutics to Release Q1 2021 Financial Results and Host Conference C..
GL
04/26PRESS RELEASE : Addex to Participate at the 4 Annual Neuroscience Innovation For..
DJ
More news
Financials
Sales 2021 1,32 M 1,46 M 1,46 M
Net income 2021 -15,1 M -16,7 M -16,7 M
Net cash 2021 11,0 M 12,2 M 12,2 M
P/E ratio 2021 -3,35x
Yield 2021 -
Capitalization 62,8 M 69,5 M 69,6 M
EV / Sales 2021 39,3x
EV / Sales 2022 70,9x
Nbr of Employees 27
Free-Float 53,6%
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 1,08 CHF
Last Close Price 1,44 CHF
Spread / Highest target -25,0%
Spread / Average Target -25,0%
Spread / Lowest Target -25,0%
EPS Revisions
Managers and Directors
NameTitle
Timothy Dyer Chief Executive Officer & Director
LÚnaic TeyssÚdou Head-Finance
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD-27.14%70
MODERNA, INC.43.46%60 177
LONZA GROUP AG-1.83%45 717
IQVIA HOLDINGS INC.30.62%44 017
CELLTRION, INC.-24.65%31 985
SEAGEN INC.-15.78%26 262